Relationship of Menopausal Status with Molecular Breast Cancer Subtypes
Phoenix Medical Journal · 2022
DOI: 10.38175/phnx.1059347 ↗Kurz gefasst
Fachartikel in der Zeitschrift Phoenix Medical Journal, 2022. Verfasst von Şeref DOKCU und 4 weiteren Autor:innen. Die Arbeit nennt 16 Literaturangaben.
Abstract (Originalsprache)
Objective
Breast cancer is a heterogeneous disease group that exhibits quite different biological behaviors and bear many genomic traces. Its dependence on sex hormones also determines its relationship with menopausal status. It is divided into five molecular subtypes according to receptor analysis and Ki67 level with immunohistochemical (IHC) markers. This study aimed to examine the relationship between the menopausal status and these molecular subtypes to help determine our treatment strategies. Material and Method The database of 250 patients who were operated on for breast cancer in our Oncology Clinic between 2012 and 2020 was retrospectively analyzed. The patients were grouped by their menopausal status and clinicopathological characteristics. Statistical analysis was made at a 95% confidence interval, and a p-value lower than 0.05 was considered statistically significant.
Results
The patients were divided into 2 groups by their menopausal status as 44.8% (n = 112) as premenopausal and 65.2% (n=138) as postmenopausal. In the statistical analysis performed, the level of Ki67 was high in premenopausal women (p=0.015). Also, tumors seen in premenopausal women were associated with ER negativity (p=0.024) and high histological grade (grade3) (p=0.015). It was found that luminal subtype (luminal A, luminal B) breast cancers were observed more frequently in postmenopausal women and non-luminal subtypes (HER2+, TNBC) were observed more frequently in premenopausal women.
Conclusion
The genomic complexity that will determine personalized treatment strategies soon remains to be clarified. There is still a need for randomized, prospective, multidisciplinary, and population-based studies to help us understand this unknown nature.
Zitieren
APA
DOKCU, Ş., ÇAPARLAR, M. A., ÇETİNDAĞ, Ö., HAKSEVEN, M., & EROĞLU, A. (2022). Relationship of Menopausal Status with Molecular Breast Cancer Subtypes. Phoenix Medical Journal. https://doi.org/10.38175/phnx.1059347
Vancouver
DOKCU Ş, ÇAPARLAR MA, ÇETİNDAĞ Ö, HAKSEVEN M, EROĞLU A. Relationship of Menopausal Status with Molecular Breast Cancer Subtypes. Phoenix Medical Journal. 2022. doi:10.38175/phnx.1059347
BibTeX
@article{DOKCU2022,
author = {DOKCU, Şeref and ÇAPARLAR, Mehmet Ali and ÇETİNDAĞ, Özhan and HAKSEVEN, Musluh and EROĞLU, Aydan},
title = {Relationship of Menopausal Status with Molecular Breast Cancer Subtypes},
journal = {Phoenix Medical Journal},
year = {2022},
doi = {10.38175/phnx.1059347}
}
EUVIMED